CNV-dopamine

• Description:

  CNV-dopamine is a photoreleasable D2 receptor-selective agonist. CNV-dopamine activates D2 receptors and induces G protein-coupled inwardly rectifying potassium (GIRK) currents. CNV-dopamine is promising for research of disorders like Parkinson’s disease and addiction[1].

• UNSPSC:

  12352005

• Target:

  Dopamine Receptor

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Applications:

  Neuroscience-Neurodegeneration

• Field of Research:

  Neurological Disease

• Smiles:

  OC1=CC(CCN)=CC=C1OC(C2=CC(OC)=C(C=C2[N+]([O-])=O)OC)C(O)=O.NCCC3=CC=C(C(OC(C4=CC(OC)=C(C=C4[N+]([O-])=O)OC)C(O)=O)=C3)O

• Molecular Formula:

  C18H20N2O8

• Molecular Weight:

  392.36

• References & Citations:

  [1]Robinson BG, et al. Desensitized D2 autoreceptors are resistant to trafficking. Sci Rep. 2017 Jun 29;7 (1) :4379.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• Isoform:

  D2 Receptor